Featured Article

FDA Offers Further RBM Guidance Stressing Data Quality Oversight

Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a new Q&A that reinforces the importance of performing risk assessments for all studies.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Press Release
CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards
Press Release
CluePoints Sponsored RBQMLive Returns for 2025
Blog
What to Expect at RBQMLive 2025: A Glimpse Into the Industry’s Leading RBQM Event
That’s a Wrap!
All three sessions are available on demand and ready to watch, revisit, save, or share.